← Open Payments lookup

WILLIAM DAVIS: Open Payments

NPI 1659581270 · PAW PAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$985 in 28 payments from 11 companies in 2025. Trend: 2023 $807 · 2024 $1,432 · 2025 $985

Food & beverage: $985
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.5$275
Neurocrine BioSciences, Inc.6$181
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$157
Axsome Therapeutics, Inc.2$144
Alkermes, Inc.3$55
Teva Pharmaceuticals USA, Inc.2$54
Supernus Pharmaceuticals, Inc.2$44
Vanda Pharmaceuticals Inc.1$21
Otsuka America Pharmaceutical, Inc.1$20
Takeda Pharmaceuticals U.S.A., Inc.1$19

Products named: COBENFY, INGREZZA, CAPLYTA, Auvelity, ARISTADA, Qelbree, AUSTEDO XR, UZEDY.

Industry payments across MI — which companies pay providers there.